首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1935258

生物可吸收血管支架市場按產品類型、材質、應用、最終用戶和地區分類

Bioresorbable Vascular Scaffold Market, By Product Type, By Material, By Application, By End User, By Geography

出版日期: 2026年01月23日 | 出版商:

Coherent Market Insights | 英文 152 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，生物可吸收血管支架市場價值將達到 4.8 億美元，預計到 2033 年將達到 9.6 億美元，2026 年至 2033 年的複合年成長率為 8.5%。

報告覆蓋範圍		報告詳情
基準年：	2025	2026年市場規模：	4.8億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	8.50%	2033 年的預測值：	9.6億美元

生物可吸收血管支架（BVS）是一種用於治療動脈阻塞的非金屬網狀管。與支架類似，它會隨著阻塞動脈功能的恢復而逐漸溶解，使動脈恢復到自然狀態。支架大約會在12到24個月內完全消失，為血管提供支撐直到其完全恢復功能。 BVS旨在疏通心臟阻塞的動脈，恢復心肌的血液供應。它們適用於各種心血管疾病患者。心血管手術常用的BVS包括聚左旋乳酸（PLLA）生物可吸收支架、金屬生物可吸收支架及混合生物可吸收支架。

市場動態

冠狀動脈疾病、缺血性心臟疾病和其他心血管疾病的高發生率推高了對生物可吸收血管支架的需求，預計這將推動市場成長。根據美國心臟協會理事會統計，2015年心血管疾病是全球首要死因，每年全球報告的死亡人數超過1,790萬人。預計到2030年，這一數字將增至超過2,360萬。根據同一資訊來源統計，2015年美國約有836,546人死於心血管疾病，約佔總死亡人數的三分之一。

此外，主要企業正採取多種策略來鞏固其市場地位，包括推出新產品、獲得FDA核准、夥伴關係和聯盟。例如，2016年7月，雅培公司獲得美國食品藥物管理局（FDA）對其生物可吸收心臟支架Absorb的核准。本產品是第一個完全可溶解的醫療設備支架。它將用於治療美國冠狀動脈疾病患者。

然而，血管成形術和冠狀動脈疾病治療中對血管移植裝置的偏好是限制全球生物可吸收血管支架市場成長的主要因素之一。此外，嚴格的監管也阻礙了市場成長。

本次調查的主要特點

本報告對生物可吸收血管支架市場進行了詳細分析，涵蓋了預測期（2018-2026 年）內的市場規模和複合年成長率（%），以 2017 年為基準年。
該報告重點介紹了各個細分市場的潛在商機，並為該市場說明了一個有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數介紹了全球生物可吸收血管支架市場主要企業的概況：公司概況、財務表現、產品系列、地理擴張、分銷策略、關鍵發展和策略。
本報告的研究結果將使企業負責人和經營團隊能夠就即將推出的產品、政府措施、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球生物可吸收血管支架市場報告的目標受群眾外包括投資者、產品製造商、經銷商、供應商、研究和諮詢公司、新參與企業和金融分析師等行業利益相關相關人員。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太其他地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

AngioDynamics, Inc.
CR Bard, Inc.
Teleflex Incorporated
B. Braun Melsungen AG
Medtronic Plc
Vygon Ltd.
Cook Medical Inc.
Argon Medical Devices, Inc.
ICU Medical, Inc.
Theragenics Corporation

第10章分析師建議

機會
分析師觀點
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI2471

Bioresorbable Vascular Scaffold Market is estimated to be valued at USD 480 Mn in 2026 and is expected to reach USD 960 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 480 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.50%	2033 Value Projection:	USD 960 Mn

Bioresorbable vascular scaffold (BVS) is a nonmetallic mesh tube, which is used to treat blocked arteries. It is similar to a stent but gradually dissolves once the blocked artery starts functioning naturally again, enabling the artery to return to its natural state. The scaffold disappears in around 12-24 months and supports the vessel until it gain its full function. BVS is designed to help open up a blocked artery in the heart and restore blood flow to the heart muscle. It is used by patients who are suffering from different types of cardiovascular diseases. Some of the commonly used BVS for cardiac procedures include Poly-L-Lactide (PLLA) bioresorbable scaffold, metallic bioresorbable scaffold, and hybrid bioresorbable scaffold.

Market Dynamics

Increasing demand for bioresorbable vascular scaffold owing to high prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to drive market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death in the world, accounting for over 17.9 million deaths per year globally, and this number is expected to increase to over 23.6 million by 2030. From the same source, cardiovascular diseases accounted for nearly 836,546 deaths in the U.S. in 2015, which is about 1 of every 3 deaths.

Moreover, key players are opting for different strategies such as new product launches, FDA approvals, partnerships, and collaborations to increase its foothold in the market. For instance, in July 2016, Abbott received the U.S. Food and Drug Administration approval for Absorb bioresorbable heart stent. This device is first-of-its-kind medical device with fully dissolving heart stents. This device will be available to treat people with coronary artery disease in the U.S.

However, preference for vascular graft devices for angioplasty and coronary artery diseases is one of the major factors restraining growth of the global bioresorbable vascular scaffold market. Furthermore, stringent regulatory scenario has also obstructed growth of the market.

Key features of the study

This report provides in-depth analysis of the bioresorbable vascular scaffold market, market size (USD Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles leading players in the global bioresorbable vascular scaffold market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Abbott Laboratories, Cook Medical, Boston Scientific Corporation, Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., B. Braun Melsungen AG, and Terumo Corporation among others
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global bioresorbable vascular scaffold market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for bioresorbable vascular scaffold market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

Product Type Insights (Revenue, USD Mn, 2026 - 2033)
- Synthetic
- Biological
Material Type Insights (Revenue, USD Mn, 2026 - 2033)
- Metal based BVS
- Polymer based BVS
Application Insights (Revenue, USD Mn, 2026 - 2033)
- Coronary Artery Stents
- Peripheral Artery Stent
- Others
End User Insights (Revenue, USD Mn, 2026 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Cardiac center
- Others
Regional Insights (Revenue, USD Mn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Key Players Insights
- AngioDynamics, Inc.
- C. R. Bard, Inc.
- Teleflex Incorporated
- B. Braun Melsungen AG
- Medtronic Plc
- Vygon Ltd.
- Cook Medical Inc.
- Argon Medical Devices, Inc.
- ICU Medical, Inc.
- Theragenics Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Global Bioresorbable Vascular Scaffold Market, By Product Type
- Global Bioresorbable Vascular Scaffold Market, By Material
- Global Bioresorbable Vascular Scaffold Market, By Application
- Global Bioresorbable Vascular Scaffold Market, By End User
- Global Bioresorbable Vascular Scaffold Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend

4. Global Bioresorbable Vascular Scaffold Market, By Product Type, 2020-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Biological
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

5. Global Bioresorbable Vascular Scaffold Market, By Material Type, 2020-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Metal based BVS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Polymer based BVS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

6. Global Bioresorbable Vascular Scaffold Market, By Application Type, 2020-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Coronary Artery Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Peripheral Artery Stent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

7. Global Bioresorbable Vascular Scaffold Market, By End User, 2020-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Cardiac center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Mn)

8. Global Bioresorbable Vascular Scaffold Market, By Region, 2020 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Material Type, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2020 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

AngioDynamics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
C. R. Bard, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Teleflex Incorporated
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
B. Braun Melsungen AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Vygon Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cook Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Argon Medical Devices, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
ICU Medical, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Theragenics Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies